ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

In Brief: Four More O.I. Awards Announced; Pediatric Clinical Trials RFP Canceled

September 6, 1985

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

US Sues St. Luc Hospital For Grant Funds, Expenses Of Data Reanalysis, Investigation

June 9, 1995